Abstract
(
) is a major human pathogen that is responsible for a wide range of systemic infections. Since its propensity to form biofilms
poses formidable challenges for both detection and treatment, tools that can be used to specifically image
biofilms are highly valuable for clinical management. Here, we describe the development of oxadiazolone-based activity-based probes to target the
-specific serine hydrolase FphE. Because this enzyme lacks homologues in other bacteria, it is an ideal target for selective imaging of
infections. Using X-ray crystallography, direct cell labeling, and mouse models of infection, we demonstrate that oxadiazolone-based probes enable specific labeling of
bacteria through the direct covalent modification of the FphE active site serine. These results demonstrate the utility of the oxadizolone electrophile for activity-based probes and validate FphE as a target for the development of imaging contrast agents for the rapid detection of
infections.